Navigation Links
Pharmaceutical Product Marketing: Launching Drugs That Outperform the Competition
Date:10/5/2007

CHAPEL HILL, N.C., Oct. 5 /PRNewswire/ -- While Megabrands are more and more an exception today and many companies invest in specialty therapeutic areas, the underlying principles of how to develop, market, sell and manage a blockbuster drug that will outperform the competition are still the same -- and are still sought after by pharmaceutical and biotech companies alike.

Best Practices, LLC's leading benchmarking report "Launching Pharmaceutical Megabrands: Best Practices in Marketing Blockbusters" delivers the critical building blocks essential for new product management pre and post launch. What separates industry leaders from other pharmaceutical executives is vital knowledge of when in the process to start building and where to focus resources during development - the report provides those answers.

For a complimentary download of research study excerpts, please visit http://www3.best-in-class.com/rr862.htm.

In the benchmarking report, research analysts compile compelling metrics, best practices and lessons learned from survey responses and in-depth interviews with 24 top executives at companies such as Pfizer, Merck, Sanofi-Aventis, GlaxoSmithKline, Eli Lilly, Amgen, Boehringer-Ingelheim and Novartis.

The myriad of insights gleaned from interviewees on such topics as marketing support investment and expense patterns for high potential products will inform all marketing and branding decision-makers throughout the drug development cycle.

To learn more about the winning tactics, proven investment patterns and other tried-and-true strategies for optimizing drug launch success, see the complimentary report summary at http://www3.best-in-class.com/rr862.htm.

To drill down on the countless metrics and best practices presented in this report contact our Solution Specialists at (919) 403-0251 or bestpractices@best-in-class.com.

If you have questions regarding your own product launch, need a health check for your marketing investments, or would like to discuss how Best Practices, LLC can support your drug marketing, launch or lifecycle initiatives, please contact Cameron Tew at 919-767-9246 or ctew@best-in-class.com.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 15 years; our clients include 43 out of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. South Africa Wins landmark case against pharmaceutical giants
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Setting up a new pharmaceutical industry in India
5. Medicis Pharmaceutical company enters pediatric market
6. Supply of Radiopharmaceuticals Hampered by Attacks
7. Pharmaceutical companies are targeting patients
8. FDA approves Watson Pharmaceuticals Oxytrol patch
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
11. Pharmaceutical industries grant for R&D to be monitored
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Leading pediatric ... peers in Washington, D.C., for the 49th Congress of the International Society of ... Vice President of the Center for Cancer and Blood Disorders at Children’s ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... one of Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. ... awards program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at ...
(Date:10/12/2017)... ... 2017 , ... In the United States, single-family home owners ... New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average is $7,000 ... property-tax rates, which contributes to the relatively lower cost of living in places ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
(Date:9/22/2017)... 22, 2017  As the latest Obamacare repeal effort ... Cassidy (R-LA) and Lindsey Graham (R-SC) ... medical device industry is in an odd place.  The ... 2.3% excise tax on medical device sales passed along ... covered patients, increased visits and hospital customers with the ...
Breaking Medicine Technology: